Population pharmacokinetics (PK) pharmacodynamics (PD) of minoxidil (MNX).

被引：0
|
作者：
Fadiran, EO
Miller, R
Ludden, T
Karkowsky, A
Parekh, A
Ferry, J
机构：
[1] US FDA, ROCKVILLE, MD 20857 USA
[2] UNIV NEBRASKA, MED CTR, DEPT PHARM SCI, OMAHA, NE 68198 USA
[3] UPJOHN CO, UPJOHN LABS, KALAMAZOO, MI 49001 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：PII46 / PII46
页数：1
相关论文
共 50 条
  • [31] LACK OF EFFECT OF FLUOXETINE ON THE PHARMACOKINETICS (PK) PHARMACODYNAMICS (PD) OF ESTAZOLAM
    CAVANAUGH, J
    SCHNECK, D
    EASON, C
    HANSEN, M
    GUSTAVSON, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 141 - 141
  • [32] Effect of age on the pharmacokinetics (pk) and pharmacodynamics (pd) of nitroglycerin (NTG).
    Xu, KJ
    Jiang, LH
    Lau, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 212 - 212
  • [33] Pharmacokinetics (PK) and pharmacodynamics (PD) of oral insulin in healthy subjects
    Kidron, Miriam
    Raz, Itamar
    Schruefer, Christian
    Shwo, Herve
    Wolfensberger, Micha
    DIABETES, 2008, 57 : A127 - A127
  • [34] Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan Importance of the Promotion of Population PK/PD Analysis
    Shoji, Kensuke
    Saito, Jumpei
    Nakamura, Hidefumi
    Matsumoto, Kazuaki
    Oda, Kazutaka
    Takesue, Yoshio
    Miyairi, Isao
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (10) : E418 - E423
  • [35] Casopitant for the prevention of post-operatine nausea and vomiting (PONV): Population pharmacokinetics and pharmacodynamics (PK/PD).
    Johnson, B. M.
    Hoke, J. F.
    Bandekar, R.
    Blackburn, L. M.
    Levin, J.
    Russo, M. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S93 - S94
  • [36] The effect of rifampin on the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban in healthy subjects
    Mendell, J.
    Chen, S.
    He, L.
    Desai, M.
    Parasrampuria, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 17 - 17
  • [37] EFFECTS OF CYCLOSPORINE (CSA) ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF DOXORUBICIN (DOX)
    RABER, SR
    RUSHING, DA
    RODVOLD, KA
    PISCITELLI, SC
    PLANK, GS
    TEWKSBURY, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 189 - 189
  • [38] Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat
    Arifah, AK
    Landoni, MF
    Lees, P
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2003, 26 (02) : 139 - 150
  • [39] Alvimopan pharmacokinetics (PK) & pharmacodynamics (PD) in patients with chronic constipation (CC).
    Schmith, VD
    Garnett, W
    Barr, WH
    Kelleher, D
    Young, M
    Sanderlin, G
    Coots, S
    Agyemang, A
    Dukes, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P49 - P49
  • [40] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TEPOXALIN IN HEALTHY MALE-SUBJECTS
    WALDMAN, SA
    OSBORNE, B
    VITOW, C
    ARGENTIERI, D
    CHOW, A
    WONG, E
    SINGER, M
    LUI, N
    MISITI, J
    BJORNSSON, TD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 152 - 152
12345